Patient Outcomes Research Group Ltd. – Trademark Portfolio

Entity Type: 03

Patient Outcomes Research Group Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include PROBE and PROBE PATIENT REPORTED OUTCOMES BURDENSAND EXPERIENCES STUDY. The owner is based in Washington, DC.

1155 23rd Street NW Suite 3A

Washington, DC 20037

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Patient Outcomes Research Group Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Patient Outcomes Research Group Ltd. have?

Patient Outcomes Research Group Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Patient Outcomes Research Group Ltd. file in?

Patient Outcomes Research Group Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Patient Outcomes Research Group Ltd.'s most well-known trademarks?

Patient Outcomes Research Group Ltd.'s registered trademark portfolio includes well-known marks such as PROBE and PROBE PATIENT REPORTED OUTCOMES BURDENSAND EXPERIENCES STUDY. These are among 2 currently registered trademarks in the portfolio.

What is Patient Outcomes Research Group Ltd.'s trademark registration success rate?

Patient Outcomes Research Group Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.